XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Millions
Total
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Class A common stock
Common Stock
Class C common stock
Common Stock
Beginning balance (in shares) at Dec. 31, 2023         79,684,170 2,921,099
Beginning balance at Dec. 31, 2023 $ 572.0 $ 693.7 $ (123.8) $ 2.1 $ 0.0 $ 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based awards vested and distributed (in shares)         353,622  
Stock-based awards vested and distributed (0.4) (0.4)        
Director shares issued (in shares)         16,110  
Amortization of restricted stock units 1.3 1.3        
Net loss (8.1)   (8.1)      
Other comprehensive income (loss) (4.8)     (4.8)    
Ending balance (in shares) at Mar. 31, 2024         80,053,902 2,921,099
Ending balance at Mar. 31, 2024 $ 560.0 694.6 (131.9) (2.7) $ 0.0 $ 0.0
Beginning balance (in shares) at Dec. 31, 2024 83,267,367       83,267,367  
Beginning balance at Dec. 31, 2024 $ 548.1 699.6 (145.3) (6.2) $ 0.0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based awards vested and distributed (in shares)         943,902  
Stock-based awards vested and distributed (1.2) (1.2)        
Director shares issued (in shares)         11,060  
Amortization of restricted stock units 2.1 2.1        
Initial vesting of common stock warrants 6.0 6.0        
Provision for common stock warrants 0.8 0.8        
Net loss (10.9)   (10.9)      
Other comprehensive income (loss) $ (0.8)     (0.8)    
Ending balance (in shares) at Mar. 31, 2025 84,222,329       84,222,329  
Ending balance at Mar. 31, 2025 $ 544.1 $ 707.3 $ (156.2) $ (7.0) $ 0.0